Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

JOURNAL ARTICLE published March 2018 in The Lancet

Authors: Masatoshi Kudo | Richard S Finn | Shukui Qin | Kwang-Hyub Han | Kenji Ikeda | Fabio Piscaglia | Ari Baron | Joong-Won Park | Guohong Han | Jacek Jassem | Jean Frederic Blanc | Arndt Vogel | Dmitry Komov | T R Jeffry Evans | Carlos Lopez | Corina Dutcus | Matthew Guo | Kenichi Saito | Silvija Kraljevic | Toshiyuki Tamai | Min Ren | Ann-Lii Cheng